TargetMol Intelligence Profile
Research Incomplete
Research coverage for this vendor is 83%. Our research on TargetMol remains incomplete — what we have verified so far is published below, and research is continuing.
Still to research:
- Entity status researched (entity_status)
- Payment methods reviewed (accepted_payment_methods)
- Public summary reviewed
Overview#
TargetMol (TargetMol Chemicals Inc.) is a Greater Boston-area (Wellesley Hills, MA) compound-library and research-chemical supplier selling directly to research buyers at targetmol.com — FIT CONFIRMED for this directory: its catalog includes a dedicated Peptide Products category (thousands of peptide listings with prices and stock status in catalog search, plus a peptide product sitemap) and its Terms offer custom synthesis expressly including peptides, alongside inhibitors, natural products, antibodies, recombinant proteins and 170+/800+ compound libraries (counts vary by source/vintage). Identity is comparatively documented for this sector: a consistent legal name on the site, SDS documents and a USPTO proceeding that pleads it is a Massachusetts corporation, and a published Washington Street, Wellesley Hills address — with two open variations (36 vs 34 Washington Street in current documents; earlier 'Target Molecule Corp.' styling in 2019) and no direct SoS record (status, formation date, registered agent, confirmed principals) retrieved in this pass. Operations are global as described by the vendor itself: headquarters in the Greater Boston area, an integrated R&D platform in Shanghai stated on About Us, a China-based domain registrar, and USA vs Global warehouse fulfillment — these are sourced operational facts; no Chinese parent or subsidiary relationship is stated in any source and none is inferred. All defined FDA/FTC/state-AG/recall/import-alert/criminal searches returned No Record Found in the defined search. The one legal proceeding found is a trademark opposition, Target Brands, Inc. v. TargetMol Chemicals Inc. (TTAB Opp. No. 91299859, 2025), alleging confusion with the TARGET retail marks — no product-safety allegation. Testing disclosure is in-house only: HNMR + HPLC/LCMS, typically >98%, per-batch COAs and testing reports displayed per the FAQ/Terms, batch purity shown on product pages — but no independent laboratory is named, no COA verification portal exists, and no test dates are displayed. Commercial terms are published (FedEx $50 inhibitors, free delivery >$300, 24-hour dispatch representation; returns only with prior authorization, shipping non-refundable, replace-or-credit for datasheet non-performance); accepted payment methods are not published. No serious (High/Critical) regulatory findings.
Company Identity#
Domain and Digital Identity#
Regulatory and Legal History#
Testing and COA Evidence#
Payment, Refund and Shipping#
Material Changes#
No material changes recorded.